Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system

Modern Pathology

Volumn 21, Issue 11, 2008, Pages 1379-1386

  Su, Min Cheng ^a   Yuan, Ray Hwang ^b   Lin, Chiao Ying ^c   Jeng, Yung Ming ^b,c  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adenocarcinoma; Cadherin 17; Immunohistochemistry

Indexed keywords

CADHERIN 17; CADHERIN 7; CYTOKERATIN 7; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; CADHERINS; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 57749109121     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.107     Document Type: Article

References (16)

1. Pavlidis N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007;46:592-601.
2. Levi F, Te VC, Erler G, et al. Epidemiology of unknown primary tumours. Eur J Cancer 2002;38:1810-1812.
3. Nadji M, Tabei SZ, Castro A, et al. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer 1981;48:1229-1232.
4. Fabbro D, Di Loreto C, Stamerra O, et al. TTF-1 gene expression in human lung tumours. Eur J Cancer 1996;32A:512-517.
5. ++-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 1994;125:1353-1369.
6. Dantzig AH, Hoskins JA, Tabas LB, et al. Association of intestinal peptide transport with a protein related to the cadherin superfamily. Science 1994;264:430-433.
7. Kreft B, Berndorff D, Böttinger A, et al. LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions. J Cell Biol 1997;136:1109-1121.
8. Wendeler MW, Drenckhahn D, Gessner R, et al. Intestinal LI-cadherin acts as a Ca2+-dependent adhesion switch. J Mol Biol 2007;370:220-230.
9. Gessner R, Tauber R. Intestinal cell adhesion molecules. Liver-intestine cadherin. Ann NY Acad Sci 2000;915:136-143.
10. Takamura M, Ichida T, Matsuda Y, et al. Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. Cancer Lett 2004;212:253-259.
11. Ito R, Oue N, Yoshida K, et al. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 2005;447:717-722.
12. Ko S, Chu KM, Luk JM, et al. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol 2005;205:615-622.
13. Takamura M, Sakamoto M, Ino Y, et al. Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci 2003;94:425-430.
14. Dennis JL, Hvidsten TR, Wit EC, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005;11:3766-3772.
15. Dennis JL, Vass JK, Wit EC, et al. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res 2002;62:5999-6005.
16. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001;159:2239-2248.